ABOUT

---

Highly specialized industry insight on the Asian marketplace, plus editor’s picks from the world press and English summaries of Chinese and Japanese news

---

Staff | Free Trial | Subscribe/Renew | Advertise

Why Read PharmAsia News?

PharmAsia News is an online portal providing around-the-clock news and analysis on regulatory, legal and financial developments affecting pharmaceutical, biologics and medical device manufacturers doing business in China, India, Japan and other nations of the Pacific Rim. The editorial team of PharmAsia News has access to a comprehensive network of insiders in industry, government and the investment community.

Subscribers get original on-the-ground reporting from news bureaus across Asia, guest columns from industry thought leaders, exclusive interviews with key decision-makers, English translation summaries of Chinese and Japanese news, and reports on intellectual property, regulatory compliance, product safety, manufacturing, clinical trials, outsourcing and more. Unlike any other Asian publication, PharmAsia News provides just the right mix of original reporting, headline news and analysis.  

Who Reads PharmAsia News?

Pharma, biotech and device professionals looking for high-quality coverage of business and regulatory developments in the Pacific Rim rely on PharmAsia News to help them monitor rapidly-changing events first-hand; anticipate regulatory and safety developments; reduce the risk of corruption violations; and understand local business customs.